Related Experiment Video
Updated: Aug 23, 2026

Building a Better Mosquito: Identifying the Genes Enabling Malaria and Dengue Fever Resistance in A. gambiae and A. aegypti Mosquitoes
Published on: July 4, 2007
Mosquitocidal toxins, genes and bacteria: the hit squad
1Institute of Molecular and Cell Biology, National University of Singapore, 10 Kent Ridge Crescent, Singapore 119260, Republic of Singapore. mcbagp@nus.sg
Abstract:
Certain entomopathogenic species of bacilli and Clostridium produce one or more toxins that kill mosquito larvae even at concentrations in the picomolar range. Altogether, 19 distinct genes are known that encode mosquitocidal toxins, which vary in their potency, species specificity and mode of action. Unlike chemical insecticides, mosquitocidal bacilli used as larvicides are safe for animals and the environment, and do not affect non-pest insects. Mosquitocidal bacteria are effective to varying degrees against Culex, Anopheles and Aedes mosquito larvae, but their rapid sedimentation from the larval feeding zone, UV-light sensitivity and narrow host range have hampered their development. New genetic engineering approaches are being investigated that could overcome these limitations and allow stable expression of broad host range combinations of toxins in UV-resistant, buoyant recombinant bacteria, as discussed here by Alan Porter.
Insights
Mosquitocidal bacteria produce potent toxins to control mosquito larvae safely and effectively. Genetic engineering aims to enhance these bacteria for broader application and environmental stability.
Area of Science:
- Microbiology
- Toxicology
- Genetics
Background:
- Certain bacteria, including bacilli and Clostridium, produce highly potent mosquitocidal toxins effective at picomolar concentrations.
- These bacterial toxins offer an environmentally safe alternative to chemical insecticides, sparing beneficial insects and animals.
- Existing bacterial larvicides face limitations like rapid sedimentation, UV sensitivity, and narrow host specificity.
Purpose of the Study:
- To review the characteristics and limitations of current mosquitocidal bacterial toxins.
- To explore novel genetic engineering strategies for improving bacterial larvicides.
- To discuss the potential for developing enhanced recombinant bacteria with broad-spectrum activity and improved field performance.
Main Methods:
- Review of existing literature on entomopathogenic bacteria and their toxins.
- Discussion of genetic engineering techniques for toxin expression and bacterial modification.
- Analysis of challenges and proposed solutions for enhancing bacterial larvicide efficacy.
Main Results:
- Identification of 19 distinct genes encoding mosquitocidal toxins with varying potencies and modes of action.
- Recognition of the environmental and safety benefits of bacterial larvicides over chemical alternatives.
- Highlighting the need for genetic modification to address limitations such as sedimentation and UV sensitivity.
Conclusions:
- Mosquitocidal bacteria represent a promising avenue for sustainable mosquito control.
- Genetic engineering holds the key to overcoming current limitations and developing next-generation bacterial larvicides.
- Future research should focus on creating UV-resistant, buoyant recombinant bacteria expressing broad-spectrum toxin combinations.
Related Concept Videos
Bacterial Toxins
Gene Regulation in Microbial Communities: Quorum Sensing
Biological Methods for Microbial Control
Regulation of Bacterial Virulence
Production of Biopesticides
CRISPR and crRNAs
The CRISPR-Cas system stores a copy of foreign DNA in the host genome and uses it to identify the foreign DNA upon reinfection. CRISPR-Cas has three different...

